Concepts (111)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Global Health | 15 | 2021 | 13911 | 1.48 | Why? |
| Neglected Diseases | 2 | 2021 | 381 | 1.12 | Why? |
| Financing, Government | 2 | 2020 | 434 | 1.10 | Why? |
| Health Expenditures | 5 | 2020 | 904 | 0.77 | Why? |
| Health Planning Organizations | 1 | 2018 | 15 | 0.75 | Why? |
| Drug Industry | 3 | 2021 | 689 | 0.72 | Why? |
| Maternal Welfare | 1 | 2018 | 40 | 0.71 | Why? |
| Financing, Organized | 1 | 2019 | 137 | 0.69 | Why? |
| Public Policy | 2 | 2020 | 1894 | 0.68 | Why? |
| Gross Domestic Product | 1 | 2018 | 134 | 0.68 | Why? |
| Healthcare Financing | 1 | 2019 | 129 | 0.67 | Why? |
| Financial Support | 2 | 2020 | 170 | 0.65 | Why? |
| Politics | 2 | 2020 | 1824 | 0.64 | Why? |
| Universities | 2 | 2021 | 4374 | 0.59 | Why? |
| Disclosure | 1 | 2020 | 423 | 0.59 | Why? |
| Health Status Indicators | 1 | 2018 | 341 | 0.57 | Why? |
| Investments | 1 | 2017 | 166 | 0.56 | Why? |
| Goals | 1 | 2018 | 335 | 0.56 | Why? |
| Conservation of Natural Resources | 1 | 2018 | 520 | 0.50 | Why? |
| Child Welfare | 1 | 2018 | 405 | 0.47 | Why? |
| Child Health | 2 | 2018 | 940 | 0.46 | Why? |
| Game Theory | 2 | 2021 | 36 | 0.43 | Why? |
| Health Care Costs | 1 | 2018 | 1007 | 0.41 | Why? |
| Health Policy | 6 | 2021 | 6242 | 0.40 | Why? |
| Health Priorities | 1 | 2018 | 959 | 0.38 | Why? |
| Income | 1 | 2018 | 1564 | 0.38 | Why? |
| Viral Vaccines | 2 | 2021 | 7560 | 0.38 | Why? |
| Commerce | 1 | 2018 | 1109 | 0.37 | Why? |
| Biomedical Research | 2 | 2020 | 5270 | 0.37 | Why? |
| Resource Allocation | 1 | 2020 | 1771 | 0.36 | Why? |
| Developing Countries | 5 | 2019 | 4283 | 0.36 | Why? |
| Communicable Diseases, Emerging | 1 | 2021 | 2523 | 0.31 | Why? |
| Periodicals as Topic | 1 | 2018 | 1492 | 0.29 | Why? |
| Public Health | 3 | 2021 | 16359 | 0.28 | Why? |
| Leadership | 1 | 2018 | 2241 | 0.27 | Why? |
| Disaster Planning | 1 | 2017 | 1680 | 0.27 | Why? |
| Health Promotion | 1 | 2017 | 2020 | 0.26 | Why? |
| National Health Programs | 1 | 2010 | 807 | 0.25 | Why? |
| Pandemics | 9 | 2021 | 389249 | 0.22 | Why? |
| Humanities | 1 | 2021 | 55 | 0.22 | Why? |
| Health Services Accessibility | 3 | 2021 | 10697 | 0.21 | Why? |
| Communicable Disease Control | 5 | 2021 | 29620 | 0.20 | Why? |
| Quarantine | 3 | 2021 | 18418 | 0.19 | Why? |
| Private Sector | 1 | 2020 | 262 | 0.17 | Why? |
| Humans | 32 | 2021 | 930598 | 0.17 | Why? |
| Developed Countries | 1 | 2021 | 500 | 0.16 | Why? |
| Epidemics | 1 | 2017 | 6407 | 0.16 | Why? |
| Economic Development | 1 | 2018 | 167 | 0.16 | Why? |
| Risk-Taking | 1 | 2020 | 508 | 0.16 | Why? |
| HIV Infections | 2 | 2020 | 11620 | 0.15 | Why? |
| Child Mortality | 1 | 2018 | 163 | 0.15 | Why? |
| International Cooperation | 3 | 2020 | 3436 | 0.14 | Why? |
| Adolescent Health | 1 | 2018 | 227 | 0.14 | Why? |
| Evidence-Based Practice | 1 | 2020 | 693 | 0.14 | Why? |
| Mortality | 3 | 2021 | 7132 | 0.14 | Why? |
| Insurance, Health | 1 | 2020 | 634 | 0.14 | Why? |
| Inventions | 1 | 2018 | 372 | 0.13 | Why? |
| Maternal Mortality | 1 | 2018 | 461 | 0.13 | Why? |
| Maternal Health | 1 | 2018 | 331 | 0.13 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.13 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.12 | Why? |
| Cooperative Behavior | 1 | 2021 | 1216 | 0.12 | Why? |
| Women's Health | 1 | 2018 | 444 | 0.12 | Why? |
| Organophosphorus Compounds | 1 | 2012 | 53 | 0.12 | Why? |
| Health Plan Implementation | 1 | 2018 | 571 | 0.12 | Why? |
| Delivery of Health Care | 4 | 2020 | 15909 | 0.12 | Why? |
| Nigeria | 1 | 2020 | 2292 | 0.12 | Why? |
| Deoxycytidine | 1 | 2012 | 116 | 0.11 | Why? |
| Child Health Services | 1 | 2018 | 520 | 0.11 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.11 | Why? |
| Vaccines | 1 | 2010 | 3692 | 0.11 | Why? |
| Motivation | 1 | 2021 | 1640 | 0.10 | Why? |
| United States | 4 | 2020 | 46150 | 0.10 | Why? |
| Maternal Health Services | 1 | 2018 | 808 | 0.09 | Why? |
| Seasons | 1 | 2021 | 4071 | 0.09 | Why? |
| Infant, Newborn | 3 | 2018 | 23105 | 0.09 | Why? |
| Decision Making | 2 | 2020 | 3132 | 0.09 | Why? |
| Internationality | 1 | 2020 | 3297 | 0.08 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.08 | Why? |
| Premature Birth | 1 | 2017 | 2151 | 0.07 | Why? |
| Health Services Needs and Demand | 1 | 2020 | 3419 | 0.07 | Why? |
| Healthcare Disparities | 1 | 2021 | 3893 | 0.06 | Why? |
| Students | 1 | 2020 | 5255 | 0.06 | Why? |
| Child | 3 | 2018 | 70012 | 0.05 | Why? |
| Primary Health Care | 1 | 2018 | 4839 | 0.05 | Why? |
| Crime | 1 | 2021 | 127 | 0.05 | Why? |
| Anti-HIV Agents | 1 | 2012 | 2209 | 0.05 | Why? |
| Healthy People Programs | 1 | 2018 | 31 | 0.05 | Why? |
| Adolescent | 2 | 2018 | 86841 | 0.04 | Why? |
| Time Factors | 1 | 2020 | 31397 | 0.04 | Why? |
| United Kingdom | 2 | 2020 | 18046 | 0.04 | Why? |
| Infant | 1 | 2018 | 30274 | 0.04 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 8811 | 0.03 | Why? |
| Child, Preschool | 1 | 2018 | 36283 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination | 1 | 2012 | 14 | 0.03 | Why? |
| Immunity, Herd | 1 | 2020 | 1011 | 0.03 | Why? |
| Policy Making | 1 | 2017 | 829 | 0.03 | Why? |
| Female | 3 | 2018 | 380317 | 0.02 | Why? |
| Evidence-Based Medicine | 1 | 2020 | 3228 | 0.02 | Why? |
| Consensus | 1 | 2020 | 6345 | 0.02 | Why? |
| United States Food and Drug Administration | 1 | 2012 | 1276 | 0.02 | Why? |
| Schools | 1 | 2020 | 4187 | 0.02 | Why? |
| Europe | 1 | 2020 | 12702 | 0.02 | Why? |
| India | 1 | 2021 | 11875 | 0.02 | Why? |
| Drug Approval | 1 | 2012 | 1325 | 0.02 | Why? |
| Drug Combinations | 1 | 2012 | 3852 | 0.01 | Why? |
| Cost-Benefit Analysis | 1 | 2012 | 2259 | 0.01 | Why? |
| Adult | 1 | 2018 | 244371 | 0.01 | Why? |
| Pregnancy | 1 | 2017 | 23879 | 0.01 | Why? |
| China | 1 | 2018 | 50654 | 0.01 | Why? |
Yamey's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(111)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(126)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_